MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
TERN Terns Pharmaceuticals
- 5.860
- -0.190-3.14%
Close Dec 20 16:00 ET
- 5.800
- -0.060-1.02%
Post 20:01 ET
497.74MMarket Cap-4.97P/E (TTM)
6.130High5.785Low4.75MVolume5.900Open6.050Pre Close27.99MTurnover8.17%Turnover RatioLossP/E (Static)84.94MShares11.40052wk High1.37P/B340.55MFloat Cap4.32052wk Low--Dividend TTM58.11MShs Float28.360Historical High--Div YieldTTM5.70%Amplitude1.450Historical Low5.893Avg Price1Lot Size
Terns Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -24.85%24.94M | 20.69%25.54M | 5.34%25.45M | 65.34%102.56M | 42.96%24.06M | 91.90%33.18M | 50.23%21.16M | 74.73%24.16M | 21.96%62.03M | 13.11%16.83M |
| Selling and administrative expenses | -46.77%9.77M | 2.53%7.19M | -3.41%6.86M | 74.29%39.06M | 6.95%6.6M | 257.69%18.35M | 29.25%7.01M | 24.82%7.1M | 14.65%22.41M | 13.92%6.17M |
| -General and administrative expense | -46.77%9.77M | 2.53%7.19M | -3.41%6.86M | 74.29%39.06M | 6.95%6.6M | 257.69%18.35M | 29.25%7.01M | 24.82%7.1M | 14.65%22.41M | 13.92%6.17M |
| Research and development costs | 2.28%15.17M | 29.69%18.35M | 8.98%18.59M | 60.28%63.5M | 63.81%17.46M | 21.96%14.83M | 63.37%14.15M | 109.64%17.06M | 26.53%39.62M | 12.64%10.66M |
| Operating profit | 24.85%-24.94M | -20.69%-25.54M | -5.34%-25.45M | -65.34%-102.56M | -42.96%-24.06M | -91.90%-33.18M | -50.23%-21.16M | -74.73%-24.16M | -24.41%-62.03M | -21.26%-16.83M |
| Net non-operating interest income expense | -11.26%3.09M | -15.29%2.88M | 18.16%3.18M | 511.42%12.9M | 150.98%3.33M | 597.39%3.48M | 1,486.45%3.4M | 3,802.90%2.69M | 1,141.18%2.11M | 2,314.55%1.33M |
| Non-operating interest income | -11.26%3.09M | -15.29%2.88M | 18.16%3.18M | 511.42%12.9M | 150.98%3.33M | 597.39%3.48M | 1,486.45%3.4M | 3,802.90%2.69M | 1,141.18%2.11M | 2,314.55%1.33M |
| Other net income (expense) | -540.00%-32K | 76.67%-14K | -200.00%-12K | -361.76%-314K | -6,025.00%-245K | 64.29%-5K | -11.11%-60K | -200.00%-4K | -270.00%-68K | -140.00%-4K |
| Other non- operating income (expenses) | -540.00%-32K | 76.67%-14K | -200.00%-12K | -361.76%-314K | -6,025.00%-245K | 64.29%-5K | -11.11%-60K | -200.00%-4K | -270.00%-68K | -140.00%-4K |
| Income before tax | 26.34%-21.88M | -27.22%-22.68M | -3.76%-22.28M | -49.98%-89.97M | -35.26%-20.97M | -76.77%-29.71M | -28.01%-17.82M | -56.11%-21.47M | -20.82%-59.99M | -12.24%-15.5M |
| Income tax | 6.90%62K | -15.28%61K | 61.67%97K | -33.24%239K | -84.59%49K | 346.15%58K | 1,100.00%72K | 185.71%60K | -29.53%358K | -26.90%318K |
| Net income | 26.28%-21.95M | -27.05%-22.74M | -3.93%-22.37M | -49.49%-90.21M | -32.85%-21.02M | -76.97%-29.77M | -28.47%-17.9M | -56.31%-21.53M | -20.31%-60.35M | -11.05%-15.82M |
| Net income continuous Operations | 26.28%-21.95M | -27.05%-22.74M | -3.93%-22.37M | -49.49%-90.21M | -32.85%-21.02M | -76.97%-29.77M | -28.47%-17.9M | -56.31%-21.53M | -20.31%-60.35M | -11.05%-15.82M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 26.28%-21.95M | -27.05%-22.74M | -3.93%-22.37M | -49.49%-90.21M | -32.85%-21.02M | -76.97%-29.77M | -28.47%-17.9M | -56.31%-21.53M | -20.31%-60.35M | -11.05%-15.82M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 26.28%-21.95M | -27.05%-22.74M | -3.93%-22.37M | -49.49%-90.21M | -32.85%-21.02M | -76.97%-29.77M | -28.47%-17.9M | -56.31%-21.53M | -20.31%-60.35M | -11.05%-15.82M |
| Basic earnings per share | 33.33%-0.28 | -24.00%-0.31 | 3.23%-0.3 | 23.95%-1.27 | 0.00%-0.29 | 4.55%-0.42 | 54.55%-0.25 | 43.64%-0.31 | 24.43%-1.67 | 48.21%-0.29 |
| Diluted earnings per share | 33.33%-0.28 | -24.00%-0.31 | 3.23%-0.3 | 23.95%-1.27 | 0.00%-0.29 | 4.55%-0.42 | 54.55%-0.25 | 43.64%-0.31 | 24.43%-1.67 | 48.21%-0.29 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.